QualiMed Innovative Medizinprodukte GmbH, based in Winsen, Germany, is a leading brand in the field of medical devices. Established in 1997, QualiMed initially focused on the development and regulatory approval of coronary stents and their delivery devices. Over time, they expanded their business to include peripheral vascular and non-vascular implants.

To stay competitive, QualiMed has diversified its product range, incorporating biodegradable technologies, drug-device combination products, and micro-intervention implants. The company has obtained CE approvals for over 70 different products, including four drug-eluting stents featuring bio stable polymers and a proprietary fast-absorbing biodegradable polymer coating. With two Class 10,000 clean rooms in Winsen, QualiMed manufactures stents, catheters, drug-device combination products, and biodegradable technologies for various interventional and surgical applications.

Their production capabilities align with EEC GMP standards, and they hold more than 70 patents and utility models worldwide. Supported by experienced board directors and investors, QualiMed continues to implement its strategic plan for operational growth and product diversification. They are committed to providing innovative medical solutions and improving patient outcomes